Rahul Gupta, director of the White House Office of National Drug Control Policy, took part in a Washington Post virtual discussion on the synthetic opioid fentanyl and the Biden administration’s ...

Drug policy and advocacy groups, alarmed by a New York Times report that the Office of Management and Budget has placed the White House’s Office of National Drug Control and Policy (ONDCP ...

The White House is calling for a 95 percent funding cut for the Office of National Drug Control Policy, the agency leading the charge against the country’s opioid epidemic, according to sources ...

A plan to move a key prevention program would effectively gut the embattled Office of National Drug Control Policy. Seeing progress in the fight against the nation’s opioid epidemic, many ...

President Donald Trump appointed Sara Carter as the next Director of the Office of National Drug Control Policy (ONDCP). He made the announcement on Friday in a post on social media platform Truth ...

One step was the Anti-Drug Abuse Act of 1988. It established the Office of National Drug Control Policy (ONDCP) within the Executive Office of the President. Headed by a director colloquially ...

The White House’s top drug policy official called for Congress to reauthorize the Office of National Drug Control Policy before the end of the year — his top legislative priority for 2024.

The Trump administration has officially commenced its war on illicit drugs with the release of the White House Office of National Drug Control Policy (ONDCP)’s Drug Policy Priorities.

Tom Marino of Pennsylvania to lead the Office of National Drug Control Policy — a position best known to the public as the nation’s “drug czar.” That did not turn out well. Following ...

NPR's Scott Simon talks to Dr. Rahul Gupta, the director of the Office of National Drug Control Policy, about how a veterinary sedative called Xylazine is worsening the country's opioid epidemic.

Stephen Yang In April, the White House Office of National Drug Control Policy designated fentanyl adulterated with xylazine as an “emerging threat” while citing a staggering 1,127% rise in ...

President Donald Trump appointed Sara Carter as the next Director of the Office of National Drug Control Policy (ONDCP). He made the announcement on Friday in a post on social media platform Truth ...